Detection and Management of Signals Associated with Adverse Drug Reactions from Atorvastatin and Rosuvastatin: An Observational Study. (2025). Vascular and Endovascular Review, 8(17s), 279-284. https://verjournal.com/index.php/ver/article/view/1272